A. Thoelke

448 total citations
7 papers, 297 citations indexed

About

A. Thoelke is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, A. Thoelke has authored 7 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in A. Thoelke's work include Cutaneous Melanoma Detection and Management (3 papers), Melanoma and MAPK Pathways (3 papers) and Asthma and respiratory diseases (2 papers). A. Thoelke is often cited by papers focused on Cutaneous Melanoma Detection and Management (3 papers), Melanoma and MAPK Pathways (3 papers) and Asthma and respiratory diseases (2 papers). A. Thoelke collaborates with scholars based in Germany, United States and Switzerland. A. Thoelke's co-authors include Dirk Schadendorf, Axel Hauschild, R. Schulz, Michael Borte, Olf Herbarth, Uwe Schlink, Irina Lehmann, Ulrike Diez, M. Rehwagen and Ulrike Rolle‐Kampczyk and has published in prestigious journals such as Clinical Cancer Research, Annals of Oncology and Allergy.

In The Last Decade

A. Thoelke

7 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Thoelke Germany	7	108	75	65	59	51	7	297
Xiaorui Han China	9	49 0.5×	70 0.9×	22 0.3×	33 0.6×	64 1.3×	16	325
U Harréus Germany	9	142 1.3×	118 1.6×	20 0.3×	50 0.8×	21 0.4×	20	371
K. Botturi France	8	32 0.3×	55 0.7×	16 0.2×	142 2.4×	61 1.2×	13	326
Debra Jones United Kingdom	7	102 0.9×	123 1.6×	44 0.7×	46 0.8×	20 0.4×	7	423
Gian Andri Thun Switzerland	12	101 0.9×	110 1.5×	65 1.0×	100 1.7×	19 0.4×	18	361
Tommaso Cavalleri Italy	9	107 1.0×	92 1.2×	74 1.1×	56 0.9×	108 2.1×	11	342
C.‐E. Lange Germany	8	23 0.2×	21 0.3×	30 0.5×	65 1.1×	27 0.5×	15	394
Sang A Park South Korea	8	76 0.7×	121 1.6×	37 0.6×	23 0.4×	138 2.7×	13	330
Rajendran Sellamuthu United States	15	38 0.4×	108 1.4×	83 1.3×	153 2.6×	61 1.2×	20	480
Mahmoud Al-Ahwal Saudi Arabia	11	127 1.2×	89 1.2×	18 0.3×	41 0.7×	15 0.3×	25	313

Countries citing papers authored by A. Thoelke

Since Specialization

Citations

This map shows the geographic impact of A. Thoelke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Thoelke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Thoelke more than expected).

Fields of papers citing papers by A. Thoelke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Thoelke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Thoelke. The network helps show where A. Thoelke may publish in the future.

Co-authorship network of co-authors of A. Thoelke

This figure shows the co-authorship network connecting the top 25 collaborators of A. Thoelke. A scholar is included among the top collaborators of A. Thoelke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Thoelke. A. Thoelke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Thoelke, A., et al.. (2007). Jo-1 positive paraneoplastic systemic sclerosis in a patient with metastatic melanoma.. PubMed. 16(4). 428–30. 11 indexed citations

2.

Ugurel, Selma, Dirk Schadendorf, Claudia Pföhler, et al.. (2006). In vitro Drug Sensitivity Predicts Response and Survival after Individualized Sensitivity-Directed Chemotherapy in Metastatic Melanoma: A Multicenter Phase II Trial of the Dermatologic Cooperative Oncology Group. Clinical Cancer Research. 12(18). 5454–5463. 63 indexed citations

3.

Schadendorf, Dirk, Axel Hauschild, Selma Ugurel, et al.. (2006). Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study. Annals of Oncology. 17(10). 1592–1597. 30 indexed citations

4.

Schadendorf, Dirk, et al.. (2004). Clinical Phase II Study of Pegylated Liposomal Doxorubicin as Second-Line Treatment in Disseminated Melanoma. Oncology Research and Treatment. 27(6). 540–544. 27 indexed citations

5.

Thoelke, A., et al.. (2004). Primary Extracutaneous Malignant Melanoma: A Comprehensive Review with Emphasis on Treatment. Oncology Research and Treatment. 27(5). 492–499. 29 indexed citations

6.

Lehmann, Irina, A. Thoelke, Uwe Schlink, et al.. (2002). T cell reactivity in neonates from an East and a West German city – results of the LISA study. Allergy. 57(2). 129–136. 37 indexed citations

7.

Lehmann, Irina, A. Thoelke, M. Rehwagen, et al.. (2002). The influence of maternal exposure to volatile organic compounds on the cytokine secretion profile of neonatal T cells. Environmental Toxicology. 17(3). 203–210. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact